RxSight Reports Q1 2026 Earnings: Revenue Declines Amid Strategic Investments
RxSight (RXST) reported a revenue decline of 18% to $30.9 million in Q1 2026, driven by lower Light Delivery Device sales and unit volumes. Despite the drop, gross margin improved slightly due to higher LAL revenue mix. The company maintained its full-year revenue guidance between $120 million and $135 million.
Topics: expenses Gross margin LDD sales net loss revenue